Genmab A GMAB
NASDAQ GMAB
$40.00 +0.43 (+1.09%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genmab A (GMAB) Other non-cash items (2023 - 2026)

Updated

Analysis

Genmab A (GMAB) Other non-cash items (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Genmab A 2.58 Bn -2.80 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 139.00 Mn
Mar 31, 2026 150.00 Mn
Mar 31, 2025 45.00 Mn
Dec 31, 2024 291.00 Mn
Mar 31, 2024 35.00 Mn
Dec 31, 2023 254.00 Mn
Mar 31, 2023 187.00 Mn
API Access

Genmab A Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=GMAB&period=max&api_key=YOUR_API_KEY